A. Sanyal

<scp>GIDEON</scp> (Global Investigation of therapeutic <scp>DE</scp> cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

Riccardo Lencioni, Masatoshi Kudo, Sheng‐Long Ye et al. · International Journal of Clinical Practice · 2013 · 222 citations

Medicine, Oncology, Pharmacotherapy +17

BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 study

A. Sanyal, Edgar D. Charles, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology · 2017 · 32 citations

Medicine, Internal Medicine, Hepatology +12

Efficacy and safety of simtuzumab for the treatment of nonalcoholic steatohepatitis with bridging fibrosis or cirrhosis: results of two phase 2b, dose-ranging, randomized, placebo-controlled trials

A. Sanyal, Manal F. Abdelmalek, AnnaMae Diehl et al. · Journal of Hepatology · 2017 · 26 citations

Medicine, Internal Medicine, Pharmacology +11

The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.

Velimir A. Luketic, A. Sanyal · PubMed · 1994 · 17 citations

Medicine, Biochemistry, Pharmacotherapy +16

Regenerate: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Multicenter Study of Obeticholic Acid Therapy for Nonalcoholic Steatohepatitis

Vlad Ratziu, A. Sanyal, Leigh MacConell et al. · Journal of Hepatology · 2016 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +9